SK Biopharmaceuticals Co., Ltd. (326030.KS)

KRW 103600.0

(-2.54%)

Long Term Debt Summary of SK Biopharmaceuticals Co., Ltd.

  • SK Biopharmaceuticals Co., Ltd.'s latest annual long term debt in 2023 was 94.48 Billion KRW , down -37.12% from previous year.
  • SK Biopharmaceuticals Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 25 Billion KRW , down 0.0% from previous quarter.
  • SK Biopharmaceuticals Co., Ltd. reported annual long term debt of 150.25 Billion KRW in 2022, up 1365.01% from previous year.
  • SK Biopharmaceuticals Co., Ltd. reported annual long term debt of 10.25 Billion KRW in 2021, down -24.43% from previous year.
  • SK Biopharmaceuticals Co., Ltd. reported quarterly long term debt of 25 Billion KRW for 2024 Q1, down -73.54% from previous quarter.
  • SK Biopharmaceuticals Co., Ltd. reported quarterly long term debt of 125.63 Billion KRW for 2023 Q1, down -16.38% from previous quarter.

Annual Long Term Debt Chart of SK Biopharmaceuticals Co., Ltd. (2023 - 2011)

Historical Annual Long Term Debt of SK Biopharmaceuticals Co., Ltd. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 94.48 Billion KRW -37.12%
2022 150.25 Billion KRW 1365.01%
2021 10.25 Billion KRW -24.43%
2020 13.57 Billion KRW 131.67%
2019 5.85 Billion KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%
2015 - KRW 0.0%
2014 - KRW 0.0%
2013 - KRW 0.0%
2012 - KRW 0.0%
2011 - KRW 0.0%

Peer Long Term Debt Comparison of SK Biopharmaceuticals Co., Ltd.

Name Long Term Debt Long Term Debt Difference
ORIENT BIO Inc. 2.43 Billion KRW -3777.76%
Green Cross Holdings Corporation 216.35 Billion KRW 56.329%
Green Cross Holdings Corporation 84.89 Billion KRW -11.301%
Pharmicell Co., Ltd. 390.21 Million KRW -24113.108%
Green Cross Corporation 84.89 Billion KRW -11.301%
GeneOne Life Science, Inc. 6.27 Billion KRW -1406.254%
Celltrion, Inc. 99.13 Billion KRW 4.69%
Samsung Biologics Co.,Ltd. 377.39 Billion KRW 74.964%
SK bioscience Co.,Ltd. 12.43 Billion KRW -659.757%
Prestige BioPharma Limited 40.87 Billion KRW -131.174%